NSB (Neuroscientific Biopharmaceuticals Ltd) Tip for this week
News due this week, with a Bio Conference in San Fran on 22nd Oct to present
TA & Chart in readiness for the week ahead on NSB Alzheimer's Trials, which will be conducted on CVN mice models, in which develop both amyloid and tau pathologies, the hallmarks most commonly associated with Alzheimer's disease.
Price History - Last Spinal Chord Injury Trials (Dated 2nd July 2019) EmtinB being the Lead candidate
- 14.5 Cents (Day before closing price on News)
- 31.5 Cents (Days opening price on Spinal Chord successful trials on Quote: Adult Rat spinal Chord Tissue)
- 43.0 Cents (Days closing price) = +200% on Animal Models
Chart Support & Resistance Points
- 14.5 Cents (Low being the Gap on Failed news)
- 33.0 Cents (Next Pivot Point or Breakout point)
- 33.0 Cents (Which is also the High around IPO listing date in July 2018)
- 43.5 Cents (Previous High on Spinal Chord Injury Trials and Data from 2nd July)
Summary
- 33.0 Cent is a major point of resistance and potential new breakout price area imo
- 33.0 Cents will become a Major New point of support on good news
- Solid News and Progression of next phase of testing can shoot NSB to anywhere ............
